Boulder Diagnostics Overview
- Founded
-
2009
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$7.9M
Boulder Diagnostics General Information
Description
Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.
Contact Information
Website
www.boulderdiagnostics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 6395 Gunpark Drive
- Suite W
- Boulder, CO 80301
- United States
Boulder Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 31-Jul-2014 | $7.9M | 00.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Boulder Diagnostics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Roy Mondesire Ph.D | Scientific Consultant |
Boulder Diagnostics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Reich Web Consulting | Corporation | Minority | 000 0000 | 000000 0 | |
| Ventac Partners | Venture Capital | Minority | 000 0000 | 000000 0 |